Page 50 - Read Online
P. 50

Page 6 of 7                                          Yellinek et al. Mini-invasive Surg 2018;2:22  I  http://dx.doi.org/10.20517/2574-1225.2018.17


               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               None.

               Conflicts of interest
               Dr. Wexner is a paid consultant and receives royalties from Intuitive Surgical Karl Storz Endoscopy, and
               Medtronic and consulting fees from Novodaq.

               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2018.


               REFERENCES
               1.   Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg 1982;69:613-6.
               2.   Marks G, Mohiuddin M, Rakinic J. New hope and promise for sphincter preservation in the management of cancer of the rectum. Semin
                   Oncol 1991;18:388-98.
               3.   Buess G, Theiss R, Günther M, Hutterer F, Pichlmaier H. Endoscopic surgery in the rectum. Endoscopy 1985;17:31-5.
               4.   Sylla P, Rattner DW, Delgado S, Lacy AM. NOTES transanal rectal cancer resection using transanal endoscopic mi crosurgery and lapa-
                   roscopic assistance. Surg Endosc 2010;24:1205-10.
               5.   Maya A, Vorenberg A, Oviedo M, da Silva G, Wexner SD, Sands D. Surg Endosc. 2014 Learning curve for transanal endoscopic micro-
                   surgery: a single-center experience. Surg Endosc 2014;28:1407-12.
               6.   Atallah SB, Albert MR. Transanal minimally invasive surgery (TAMIS) versus transanal endoscopic microsurgery (TEM): is one better
                   than the other? Surg Endosc 2013;27:4750-1.
               7.   Atallah SB, Larach S, deBeche-Adams TC, Albert MR. Transanal minimally invasive surgery (TAMIS): a technique that can be used for
                   retrograde proctectomy. Dis Colon Rectum 2013;56:931.
               8.   Atallah S, Albert M, Debeche-Adams T, Nassif G, Polavarapu H, Larach S. Transanal minimally invasive surgery for total mesorectal
                   excision (TAMIS–TME): a stepwise description of the surgical technique with video demonstration. Tech Coloproctol 2013;17:321-5.
               9.   Atallah S, Martin-Perez B, Albert M, deBeche-Adams T, Nassif G, Hunter L, Larach S. Transanal minimally invasive surgery for total
                   mesorectal excision (TAMIS–TME): results and experience with the first 20 patients undergoing curative-intent rectal cancer surgery at
                   a single institution. Tech Coloproctol 2014;18:473-80.
               10.  Lacy AM, Tasende MM, Delgado S, Fernandez-Hevia M, Jimenez M, De Lacy B, Castells A, Bravo R, Wexner SD, Heald RJ. Transanal
                   Total Mesorectal Excision for Rectal Cancer: Outcomes after 140 Patients. J Am Coll Surg 2015;221:415-23.
               11.  de Lacy FB, van Laarhoven JJEM, Pena R, Arroyave MC, Bravo R, Cuatrecasas M, Lacy AM. Transanal total mesorectal excision:
                   pathological results of 186 patients with mid and low rectal cancer. Surg Endosc 2018;32:2442-7.
               12.  Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, Moran B, Hanna GB, Mortensen NJ, Tekkis PP; TaTME Registry
                   Collaborative. Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases. Ann Surg 2017;266:111-7.
               13.  Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, Moran B, Hanna GB, Mortensen NJ, Tekkis PP; International
                   TaTME Registry Collaborative. Incidence and risk factors for anastomotic failure in 1594 patients treated by transanal total mesorectal
                   excision: results from the International TaTME Registry. Ann Surg 2018 Jan 5. doi: 10.1097/SLA.0000000000002653.
               14.  Koedam TW, van Ramshorst GH, Deijen CL, Elfrink AK, Meijerink WJ, Bonjer HJ, Sietses C, Tuynman JB. Transanal total mesorectal
                   excision (TaTME) for rectal cancer: effects on patient-reported quality of life and functional outcome. Tech Coloproctol 2017;21:25-33.
               15.  Marks JH, Myers EA, Zeger EL, Denittis AS, Gummadi M, Marks GJ. Long-term outcomes by a transanal approach to total mesorectal
                   excision for rectal cancer. Surg Endosc 2017;31:5248-57.
               16.   Perdawood SK, Thinggaard BS, Bjoern MX. Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term
                   outcomes with laparoscopic and open surgeries. Surg Endosc 2018; 32:2312-21.
               17.  Deijen CL, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk ES, Sietses C, Tuynman JB, Lacy AM, Hanna GB, Bonjer HJ. COLOR
                   III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg En-
                   dosc 2016;30:3210-5.
               18.  Lelong B, de Chaisemartin C, Meillat H, Cournier S, Boher JM, Genre D, Karoui M, Tuech JJ, Delpero JR; French Research Group of
                   RectalCancer Surgery (GRECCAR). A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional out-
                   come of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL):
   45   46   47   48   49   50   51   52   53   54   55